Augmedix (AUGX) Insider Trading & Ownership $2.35 0.00 (0.00%) As of 10/2/2024 Add Compare Share Share Insider Trades Stock AnalysisEarningsInsider TradesBuy This Stock Augmedix (OTCMKTS:AUGX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.97%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$119.65KNumber OfInsiders Selling(Last 3 Years)8Amount OfInsider Selling(Last 3 Years)$58.72K Get AUGX Insider Trade Alerts Want to know when executives and insiders are buying or selling Augmedix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AUGX Insider Buying and Selling by Quarter Augmedix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2023Margie L TraylorDirectorBuy26,530$4.51$119,650.30 10/5/2022Mckesson Ventures, LlcMajor ShareholderSell3,307$1.30$4,299.10 10/3/2022Mckesson Ventures, LlcMajor ShareholderSell1,779$1.41$2,508.39 9/30/2022Mckesson Ventures, LlcMajor ShareholderSell12,194$1.46$17,803.24 9/28/2022Mckesson Ventures, LlcMajor ShareholderSell1,000$1.50$1,500.00 9/26/2022Mckesson Ventures, LlcMajor ShareholderSell2,300$1.56$3,588.00 9/23/2022Mckesson Ventures, LlcMajor ShareholderSell12,113$1.58$19,138.54 9/21/2022Mckesson Ventures, LlcMajor ShareholderSell720$1.92$1,382.40 9/19/2022Mckesson Ventures, LlcMajor ShareholderSell3,900$2.18$8,502.00 (Data available from 1/1/2013 forward) AUGX Insider Trading Activity - Frequently Asked Questions Who is on Augmedix's Insider Roster? The list of insiders at Augmedix includes Margie L Traylor, and Mckesson Ventures, Llc. Learn more on insiders at AUGX. What percentage of Augmedix stock is owned by insiders? 10.97% of Augmedix stock is owned by insiders. Learn more on AUGX's insider holdings. Augmedix Key ExecutivesMr. Emmanuel Krakaris (Age 65)President, CEO, Secretary & Director Compensation: $814.62kMr. Ian Shakil (Age 40)Founder, Chief Strategy Officer & Director Compensation: $375.92kMs. Sandra Breber (Age 66)Chief Operating Officer Compensation: $577.96kMr. Paul Louis Ginocchio (Age 54)Chief Financial Officer Mr. Saurav Chatterjee Ph.D. (Age 52)Chief Technology Officer Compensation: $438.05kMr. Todd HolvickHead of Legal & ComplianceMs. Lia WallickHead of PeopleDr. Davin Lundquist M.D.Chief Medical OfficerMr. Jonathan Hawkins (Age 54)Chief Revenue Officer Compensation: $417.71kMr. Tomer Levy (Age 50)Senior Vice President of Engineering More Insider Trading Tools from MarketBeat Related Companies Advantage Solutions Insider Transactions Conduent Insider Transactions Rimini Street Insider Transactions Paysign Insider Transactions IBEX Insider Transactions Absci Insider Transactions Ooma Insider Transactions Lightbridge Insider Transactions ReposiTrak Insider Transactions Arrive AI Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (OTCMKTS:AUGX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
